Status:
COMPLETED
18FDG PET Textural Indices in Adrenal Lesion
Lead Sponsor:
University Hospital, Brest
Conditions:
Adrenal Tumor
Eligibility:
All Genders
18+ years
Brief Summary
Tumors are characterized by a great heterogeneity. Characterizing this intra-tumor heterogeneity is a major challenge in oncology to improve the therapeutic management and move towards personalized me...
Eligibility Criteria
Inclusion
- Having benefited from a 18-FDG PET-CT scan in the nuclear medicine department of University Hospital of Brest
- Addressed in the context of an assessment of an adrenal lesion, in the evaluation of an extra-adrenal neoplasia or other motive
- presenting an adrenal lesion
- From June 29, 2012 to June 30, 2017
Exclusion
- Patients followed in another center than the University Hospital of Brest
- Lesions of undetermined nature
- Diagnosis of benignity or malignancy not confirmed by anatomopathology.
- Patient having expressed his opposition to the use of his medical data
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 27 2018
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03469102
Start Date
March 1 2018
End Date
July 27 2018
Last Update
July 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609